Skip to main content
Signal8

EoCene Ltd. (EOCN)

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

Eocene Ltd. logo

Eocene Ltd.

NASDAQ:EOCNHealthcare
AH+0.00%$2.46
Close$2.46-2.77%
Mkt Cap$2.63M
EV-
Float1.03M
O/S1.07M
VOL10K sh
$ Vol$24K
RVOL1.34×
Inst Own1.4%
SI0.8%
Net Cash/Sh-
Dilution
Eocene Ltd. logoNASDAQ:EOCNAH$2.46+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 17, 20262.382.462.362.4610,161
Nov 16, 20262.482.542.212.537,589
Nov 13, 20262.322.482.322.48731
Nov 12, 20262.392.512.272.393,431
Nov 11, 20262.572.572.052.4829,708
Nov 10, 20262.482.792.482.703,863
Nov 9, 20262.982.982.512.753,395
Nov 6, 20262.452.742.452.743,714
Nov 5, 20262.652.672.302.4516,421
Nov 4, 20262.772.812.772.771,142
Nov 3, 20262.913.002.692.8113,725
Nov 2, 20263.093.092.752.879,810
Oct 30, 20263.083.393.073.103,114
Oct 29, 20263.173.483.173.226,759
Oct 28, 20263.093.313.003.207,384
Oct 27, 20263.063.193.063.082,092
Oct 26, 20263.103.283.103.153,578
Oct 23, 20263.113.272.963.038,768
Oct 22, 20263.043.102.963.087,146
Oct 21, 20262.973.122.903.127,059
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
1.4%
Institutional
(9)
1.3%
Insiderⓘ
(6)
2.5%
5%+ Owners
(2)
94.7%
Unattributed (incl. retail)ⓘ
Institutional1.4%
Insider1.3%
5%+ Beneficial2.5%
Unattributed (incl. retail)94.7%
Sources: 13F, Form 4, 13D/13GO/S: 1.1M · as of 1 Sep 2026 · SEC filings
Insiders & Institutional Holders
About

Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH).

Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.

The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

Key Metrics
Market Cap$2.63M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership1.43%

based on 1.07M shares outstanding

SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeNASDAQ
CountryILIL
IPO Date-
Shares Outstanding1.07M
Authorized Shares
Float1.03M
52-Week Range
Volume
Average Daily Volume7.46K
10.16K today vs 7.46K avg(+36%)

30d Avg

7.46K

60d Avg

7.58K

90d Avg

12.51K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of EOCN as of Dec 31, 2025 records an effective F-3 shelf registration (effective Nov 21, 2024) and 1 outstanding warrant series, from SEC filings. EoCene Ltd. (NASDAQ: EOCN) traded at $2.46 on Nov 17, 2026, down 2.77% from the previous close of $2.53. The company is in the Healthcare sector (Medical - Pharmaceuticals).